The global pulmonary drug delivery technology market is projected to grow at a CAGR of approximately 5% over the next five years. This growth is driven by the rising prevalence of respiratory diseases ...

If you’re struggling with your sleep and you can’t work out why, a sleep tracker might help. On its own, it won’t solve your ...

Good afternoon, and thank you for joining the Inovio Fourth Quarter and Full Year 2025 Financial Results Conference Call. Joining me on today's call are Dr. Jacqui Shea, President and Chief Executive ...

The Journal of the American Medical Association (JAMA Neurology) publication highlights consistent clinical and biomarker findings from NeuroSense PARADIGM Phase 2b ...

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2025 Earnings Call Transcript March 12, 2026 Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.31, expectations were $-0.358.

NASDAQ: ICU John Viglotti: Hello, and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we're very pleased you joined us for the first ...

No clinical study during dental treatment abroad for few min. Shipping extra on release? Triple root and source target was also crushed. Tip amount to expect? Core menu work is rough for us everyday ...

Most hypnotics (sleep medications) for insomnia (sleep disorder) do not worsen obstructive sleep apnea but emphasize the need ...

Katherine Quesenberry, DVM, MPH, DABVP (Avian), chief medical officer, senior veterinarian, specialist in avian medicine and service head of avian and exotic medicine for Schwarzm ...

Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...

Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...